Bli medlem
Bli medlem

Du är här


Vida Cannabis Corp. : Vida Cannabis Corp. Engages Quantum 9, North America's Leading Cannabis Consulting Firm

Toronto, Ontario - April 17, 2014 - Vida Cannabis Corp.
("Vida Cannabis") is pleased to announce that Quantum 9 Inc. has been retained
to provide consulting, technology and implementation services. Quantum 9
) is North America's pre-eminent authority on cannabis cultivation consulting
and technology services, with extensive experience in working with Health
Canada'sMarihuana for Medical Purposes Regulations

The Quantum 9 team is comprised of experts in the critical areas of security,
quality assurance, the producer licensing process, facility design and
maximizing production yields. They are a proven 'blueprint-to-harvest'
service provider to several large-scale medical and recreational marijuana
companies in the United States, Canada and Europe.

Vida Cannabis CEO Greg Wilson stated: "I look forward to working with Michael
Mayes and the Quantum 9 team on finalizing our MMPR application, and in
designing a state-of-the-art production facility that will be nearly twice
the size of any currently licensed producer in Canada. Quantum 9's experience
in assisting with the administrative process of licensure applications will
be extremely valuable in completing this integral step. Our retainer of
Quantum 9 is yet another example of Vida's forward-looking, high quality
stewardship, which shareholders should continue to expect from the Company."

Quantum 9 has been on location in Stellarton and personnel are in the process
of finalizing the security and facility design to optimize the build-out of
Vida's 315,000-square-foot facility, including an initial production area of
approximately 30,000 square feet, with a roadmap for expansion driven by
market demand.

Michael Mayes, CEO of Quantum 9, stated: "We are very excited about our
partnership with Vida Cannabis. Their executive staff rivals that of the best
we have seen in the industry and we are excited to bring our expert
experience to ensure a best-in-class operation."

CEO Greg Wilson continued: "We are well underway with our application, and
expect to submit it to Health Canada in the next four weeks. In addition, I
met with our security consultant, Derek Ogden, a senior executive with 27
years service with the RCMP, on-site this week to finalize the minimum
level-9 security plan and start work on its implementation. Security is a top
priority for Vida, and it is our intention to build our facility to standards
that exceed the requirements set out by Health Canada. In some areas of
security design we will be implementing level 10 and 11 measures."

About Vida Cannabis Corp.

About Vida Cannabis

Vida Cannabis Corp. ("Vida Cannabis") is focused on developing a dominant
production footprint in the rapidly developing global marketplace for the
legal use of medicinal and recreational marijuana.

Initial operations are focused on the Canadian market where Health Canada has
established national guidelines enabling best-in-class producers to acquire
commercial production licenses under theMarihuana for Medical Purposes

Via its wholly owned subsidiary, Vida Cannabis (Canada) Ltd., Vida Cannabis
purchased a 315,000-square-foot production facility in the town of
Stellarton, Nova Scotia and secured a 50-year irrevocable approval
unanimously from the local municipality to operate a medical marijuana
production plant at the facility.

The highly secure facility boasts a fully engineered concrete floor,
18-foot-high concrete walls and a steel roof making it an ideal location for
the construction of a customized, state-of-the-art modern medical marijuana
production plant.

Vida Cannabis is working with one of the most talented cannabis consulting
teams in the world, Quantum 9 Inc., which has extensive resources in the
United States, Canada and Europe, to establish an optimized end-to-end
production plan to help position Vida Cannabis with the largest, most
advanced medical marijuana facility in Canada.

Vida Cannabis continues to evaluate additional potential markets as regulatory
bodies around the world pass legislation enabling the production and
distribution of medicinal or recreational marijuana.

About Quantum 9

Quantum 9 provides sustainable solutions for the cannabis industry using
horticultural process management making efficient use of scarce natural
resources like water and energy. Through implementing cultivation automation,
technology, and business process optimization, companies scale to more
profitable farming, effectively improving quality and yield to meet growing
demand. The Quantum 9 staff includes some of the most brilliant minds in the
field with a focus on helping organizations evolve from market gardening to
industrial horticulture.

Quantum 9 offersMarijuana for Medical Purposes Regulations
(MMPR) production license preparation documentation and consulting services.
The Quantum 9 team helps clients drive the process from blueprint to harvest,
with over 30 years of experience in cultivating and perfecting our delivery

Quantum 9 staffs Engineers, Architects, General Contractors, Horticulturists,
Botanist and Plant Nutritionist with expert level experience that will help
develop an enterprise project plan that take into account pest and pathogen
protection ensuring the cultivation of high grade medicine. Consulting areas
include, for example: Architectural Blueprinting; HVAC, Electrical, Plumbing;
Room Layout Space Optimization; Security Planning; General Contractor
Acquisition; Wholesale Equipment Acquisition; Laboratory Testing Assignment;
Reverse Traceability Technology; Plant Health Optimization; Production

To learn more about Quantum 9, visit their website

On behalf of the board,

Greg Wilson - Director&CEO
Vida Cannabis Corp.

Investor Services
Toll free +1 800 593 1585
Direct: +1 647 560 4482

This announcement does not constitute or form part of, and shall under no
circumstances be considered as, an offer to sell, a solicitation to purchase,
or advice on investments in any securities of Vida Cannabis Corp. ("Vida
Cannabis"). Offers and solicitations shall be expressly identified as such
and made in compliance with applicable securities laws. This announcement is
for information purposes only. It should not be relied upon as a basis for
investment decisions. You should consult with your own investment,
accounting, legal and tax advisers to evaluate independently the risks,
consequences and suitability of any investments you are considering. Whilst
the information provided here is believed to be reliable, it cannot be
guaranteed. It may contain forward-looking statements made by or on behalf of
Vida Cannabis about its business or financial objectives, position,
strategies or expectations. Such forward-looking statements may be identified
by words such as, or similar to, "intends," "anticipates," "believes,"
"expects" and "hopes" and includes, without limitation, the development of
production facilities, approval from regulatory authorities and the ability
for Vida Cannabis to obtain adequate financing to meet its business
objectives. These statements involve inherent risks and uncertainties that
could cause actual results to differ materially from those indicated. The
statements in this announcement do not guarantee future performance. Vida
Cannabis does not undertake any obligation to update any information provided
in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned
subsidiary of Vida Cannabis, must obtain approval from Health Canada in order
to operate as a licensed commercial producer under theMarihuana for Medical
Purposes Regulations
. Vida Cannabis makes no representations or warranties that it will receive
Health Canada approval.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vida Cannabis Corp. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.